CLAIM #48266 · Pfizer Inc (PFE) · 2023Q2 earnings call · Aug 1, 2023 · due Dec 31, 2024
“That should come later this year, and we’ll update you with the final analysis for the study then in 2024.”
Chris Boshoff · Chief Oncology R&D Officer
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for PFE ↗ · Claim quote is verbatim from the 2023Q2 earnings call.